In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Brought to you by

Sinclair Pharma closes £8.9mm IPO

21 Dec 2003

Executive Summary

Niche market pharmaceutical developer Sinclair Pharma PLC (specializing in dermatology, oral health, and oncology) has completed its IPO on the London Stock Exchange's AIM, netting £8.9mm ($15.4mm) through the sale of 9.4mm ordinary shares at 115p apiece. Selling stockholders placed an additional 9.6mm shares.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies

UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By